Skip to main content

Table 1 Case reports on percutaneous coronary intervention in patients with idiopathic thrombocytopenic purpura

From: Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review

Study Pt age (Y) and sex CAD Pre-PCI
PLT count
Antiplatelet agent before and during PCI Treated vessels PCI and approach Treatment of ITP Bleeding Restenosis Discharge therapy
Fuchi et al., 1999 [20] (twice) 72, F NSTEMI 59 None LAD PTCA, Femoral STER Large hematoma NA None
STEMI 23 None LAD PTCA, Femoral STER
Caputo et al., 2000 [6] 62, M Unstable angina 3 NA LAD BMS stenting, Radial STER No NA ASA Clop
Segal et al., 2001 [21] 49, M NSTEMI 41 ASA
RCA, LCX BMS stenting, Femoral STER No NA ASA Clop
Kikuchi et al., 2002 [22] 68, F STEMI 22 Ticlopidine LAD BMS stenting, Femoral NA No No Ticlopidine
Méndez et al., 2004 [23] 70, M NSTEMI 170 ASA
RCA, LCX BMS stenting, Radial IVIG
Stouffer et al., 2004 [24] (twice) 77, M Unstable angina 64 ASA LCX PTCA None No yes ASA
NSTEMI 78 ASA Eptifibatide LCX BMS stenting STER Petechiae No ASA Clop
Amit et al., 2005 [25] 46, M NSTEMI 38 ASA LAD PTCA IVIG No NA ASA
Marques et al., 2005 [26] 54, M Unstable angina 15 None LAD, LCX BMS stenting, Brachial STER
No NA None
Kim et al., 2006 [27] 47, F STEMI 21 Clop RCA BMS stenting, Femoral IVIG ECC NA ASA Clop
Fong et al., 2006 [28] 71, F NSTEMI 119 ASA LAD DES stenting, Radial STER
No No ASA Clop
Park et al., 2007 [29] 3 times 61, F Stable angina 4 None None CAG, Femoral STER Hematoma No None
34 None LAD, LCX BMS stenting, Femoral STER
No yes None
20 None LAD, LCX PTCA, Femoral STER No NA None
Gracia et al., 2008 [30] 37, M STEMI 39 ASA Clop LAD BMS stenting, Femoral None No NA ASA Clop
Moretti et al., 2008 [31] (twice) 66, M Unstable angina 110 NA RCA, LCX BMS stenting STER
No NA ASA Clop
200 NA LM, LAD DES stenting, Femoral STER No NA ASA Clop
Can et al., 2009 [32] 76, M Stable angina 100 Clop LAD BMS stenting, Femoral Danazol No NA NA
Yildiz et al., 2010 [33] 23, F STEMI 35 Clop LAD BMS stenting, Femoral STER ECC NA ASA Clop
Neskovic et al., 2010 [34] 80, M STEMI 5 ASA Clop LAD BMS stenting, Femoral STER Danazol No NA ASA Clop
Torbey et al., 2013 [35] 2 cases 61, F STEMI 322 ASA Clop Abciximab LAD DES stenting, Femoral SPL
55, M NSTEMI 208 Clop Obtusemarginal branch DES stenting, Femoral STER
No yes ASA Clop
  1. Pt patient, Y years, F femal, M male, CAD coronary artery disease, NSTEMI non-ST elevation myocardial infarction, STEMI ST elevation myocardial infarction, PCI percutaneous coronary intervention, PLT Platelet, NA data not available, ASA acetylsalicylic acid, Clop clopidogrel, LAD left anterior descending artery, RCA right coronary artery, LCX left circumflex artery, LM left main artery, PTCA Percutaneous transluminal coronary angioplasty, BMS bare metal stent, DES drug-eluting stent, ITP idiopathic thrombocytopenic purpura, STER steroids, IVIG intravenous immunoglobulin, PLTT Platelets transfusion, SPL Splenectomy, ECC Ecchymoses